Claudius Mueller, Ph.D. - Publications

Affiliations: 
2008 Loma Linda University, Loma Linda, United States 

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Schrag M, Mueller C, Zabel M, Crofton A, Kirsch WM, Ghribi O, Squitti R, Perry G. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis. Neurobiology of Disease. 59: 100-10. PMID 23867235 DOI: 10.1016/J.Nbd.2013.07.005  0.723
2012 Zabel M, Schrag M, Mueller C, Zhou W, Crofton A, Petersen F, Dickson A, Kirsch WM. Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study. Journal of Alzheimer's Disease : Jad. 30: 311-21. PMID 22426016 DOI: 10.3233/Jad-2012-112012  0.771
2012 Mueller C, Schrag M, Crofton A, Stolte J, Muckenthaler MU, Magaki S, Kirsch W. Altered serum iron and copper homeostasis predicts cognitive decline in mild cognitive impairment. Journal of Alzheimer's Disease : Jad. 29: 341-50. PMID 22232013 DOI: 10.3233/Jad-2011-111841  0.806
2011 Schrag M, Mueller C, Oyoyo U, Smith MA, Kirsch WM. Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion. Progress in Neurobiology. 94: 296-306. PMID 21600264 DOI: 10.1016/J.Pneurobio.2011.05.001  0.76
2010 Mueller C, Zhou W, Vanmeter A, Heiby M, Magaki S, Ross MM, Espina V, Schrag M, Dickson C, Liotta LA, Kirsch WM. The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 19: 1081-91. PMID 20157261 DOI: 10.3233/Jad-2010-1303  0.796
2010 Schrag M, McAuley G, Pomakian J, Jiffry A, Tung S, Mueller C, Vinters HV, Haacke EM, Holshouser B, Kido D, Kirsch WM. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathologica. 119: 291-302. PMID 19937043 DOI: 10.1007/S00401-009-0615-Z  0.777
2009 Mueller C, Magaki S, Schrag M, Ghosh MC, Kirsch WM. Iron regulatory protein 2 is involved in brain copper homeostasis. Journal of Alzheimer's Disease : Jad. 18: 201-10. PMID 19584448 DOI: 10.1016/J.Jalz.2009.04.754  0.795
2009 Kirsch W, McAuley G, Holshouser B, Petersen F, Ayaz M, Vinters HV, Dickson C, Haacke EM, Britt W, Larseng J, Kim I, Mueller C, Schrag M, Kido D. Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. Journal of Alzheimer's Disease : Jad. 17: 599-609. PMID 19433895 DOI: 10.3233/Jad-2009-1073  0.801
2009 Kirsch WM, McAuley G, Vinters HV, Britt W, Mueller C, Liotta L, Schrag M, Dickson C, Kido D, Holshouser B, Petersen F, Haacke EM, Ayaz M. O1-01-05: Brain microvascular fragility is a major cause of Alzheimer's disease Alzheimer's & Dementia. 5: P77-P78. DOI: 10.1016/J.Jalz.2009.05.191  0.759
2009 Mueller C, Zhou W, Ross MM, VanMeter A, Heiby M, Espina V, Dickson C, Liotta L, Kirsch W. P3-015: Identification of serum biomarker candidates for Alzheimer's disease Alzheimer's & Dementia. 5: P344-P345. DOI: 10.1016/J.Jalz.2009.04.1192  0.611
2008 Olson BL, Holshouser BA, Britt W, Mueller C, Baqai W, Patra S, Petersen F, Kirsch WM. Longitudinal metabolic and cognitive changes in mild cognitive impairment patients. Alzheimer Disease and Associated Disorders. 22: 269-77. PMID 18580584 DOI: 10.1097/Wad.0B013E3181750A65  0.607
2008 Magaki S, Yellon SM, Mueller C, Kirsch WM. Immunophenotypes in the circulation of patients with mild cognitive impairment. Journal of Psychiatric Research. 42: 240-6. PMID 17320906 DOI: 10.1016/J.Jpsychires.2007.01.004  0.752
2007 Magaki S, Mueller C, Yellon SM, Fox J, Kim J, Snissarenko E, Chin V, Ghosh MC, Kirsch WM. Regional dissection and determination of loosely bound and non-heme iron in the developing mouse brain. Brain Research. 1158: 144-50. PMID 17560557 DOI: 10.1016/J.Brainres.2007.05.004  0.756
2007 Magaki S, Raghavan R, Mueller C, Oberg KC, Vinters HV, Kirsch WM. Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias. Neuroscience Letters. 418: 72-6. PMID 17408857 DOI: 10.1016/J.Neulet.2007.02.077  0.78
2007 Magaki S, Mueller C, Dickson C, Kirsch W. Increased production of inflammatory cytokines in mild cognitive impairment. Experimental Gerontology. 42: 233-40. PMID 17085001 DOI: 10.1016/J.Exger.2006.09.015  0.706
2007 Hong S, Mueller C, Magaki S, Petersen F, Kirsch WM. APOLIPOPROTEIN E GENOTYPE FREQUENCIES IN A PROSPECTIVE STUDY OF SPORADIC LATE -ONSET DEMENTIA. Journal of Investigative Medicine. 55: S99. DOI: 10.1097/00042871-200701010-00144  0.744
2006 Coon KD, Siegel AM, Yee SJ, Dunckley TL, Mueller C, Nagra RM, Tourtellotte WW, Reiman EM, Papassotiropoulos A, Petersen FF, Stephan DA, Kirsch WM. Preliminary demonstration of an allelic association of the IREB2 gene with Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 9: 225-33. PMID 16914832 DOI: 10.3233/Jad-2006-9301  0.636
2006 Fox J, Mueller C, Magaki S, Obenaus A, Haacke EM, Kirsch WM. 367 SUSCEPTIBILITY WEIGHTED IMAGING: VALIDATION OF AN INNOVATIVE MAGNETIC RESONANCE IMAGING TECHNIQUE FOR MEASURING BRAIN IRON. Journal of Investigative Medicine. 54: S143.4-S143. DOI: 10.2310/6650.2005.X0004.366  0.757
2006 Magaki S, Mueller C, Dickson C, Kirsch W. P1-149: Increased levels of proinflammatory cytokines in mild cognitive impairment compared to healthy aged controls Alzheimer's & Dementia. 2: S139-S139. DOI: 10.1016/J.Jalz.2006.05.525  0.727
2006 Mueller C, Magaki S, Robbins M, Dickson C, Snissarenko E, Fox J, Kim J, Chin V, Deming D, Obenaus A, Yellon S. P1-080: Susceptibility weighted imaging - validation of an innovative MR imaging technique for measuring brain iron Alzheimer's & Dementia. 2: S118-S118. DOI: 10.1016/J.Jalz.2006.05.455  0.666
2006 Mueller C, Magaki S, Kirsch WM. P3-367: Assessment of altered blood/brain iron metabolism as a risk factor for the development of Alzheimer's disease Alzheimer's & Dementia. 2: S483-S483. DOI: 10.1016/J.Jalz.2006.05.1637  0.765
2006 Magaki S, Kelln W, Mueller C, Raghavan R, Jeong J, Woods K, Oberg K, Tourtellotte W, Vinters H, Kirsch W. P3-188: Immunohistochemical localization of iron regulatory protein-2 in Alzheimer's disease hippocampus Alzheimer's & Dementia. 2: S430-S430. DOI: 10.1016/J.Jalz.2006.05.1456  0.766
2006 Mueller C, Bartnik BL, Patra S, Baqai W, Petersen F, Holshouser BA, Kirsch WM. P2-349: Analysis of metabolite levels and ratios in age matched controls, mild cognitive impairment, and Alzheimer's disease converters using 1 H magnetic resonance spectroscopy Alzheimer's & Dementia. 2: S344-S344. DOI: 10.1016/J.Jalz.2006.05.1189  0.615
2005 Chin V, Snissarenko E, Anton L, Kim I, Mueller C, Magaki S, Obenaus A, Kirsch WM. 352 ISOLATION OF DISCRETE REGIONS OF THE BRAIN FROM IRON REGULATORY PROTEIN-2 KNOCKOUT MICE Journal of Investigative Medicine. 53: S140.1-S140. DOI: 10.2310/6650.2005.00005.351  0.76
Show low-probability matches.